Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx Trial.

Authors	Jennifer A Whitty, Jenny Rankin, Dina Visca, Vicky Tsipouri, Letizia Mori, Lisa Spencer, Huzaifa Adamali, Toby M Maher, Nicholas S Hopkinson, Surinder S Birring, Morag Farquhar, Athol U Wells, Piersante Sestini, Elisabetta A Renzoni
Journal	The European respiratory journal (Eur Respir J) Vol. 55 Issue 2 (02 2020) ISSN: 1399-3003 [Electronic] England
PMID	31699838 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References	Oxygen
Topics	Ambulatory Care Cost-Benefit Analysis Humans Lung Diseases Oxygen Quality of Life Quality-Adjusted Life Years

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!